Annual Current Liabilities
$3.43 B
+$161.50 M+4.93%
December 31, 2023
Summary
- As of February 7, 2025, BIIB annual total current liabilities is $3.43 billion, with the most recent change of +$161.50 million (+4.93%) on December 31, 2023.
- During the last 3 years, BIIB annual current liabilities has fallen by -$307.90 million (-8.23%).
- BIIB annual current liabilities is now -29.39% below its all-time high of $4.86 billion, reached on December 31, 2019.
Performance
BIIB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.42 B
+$2.32 B+74.54%
September 30, 2024
Summary
- As of February 7, 2025, BIIB quarterly total current liabilities is $5.42 billion, with the most recent change of +$2.32 billion (+74.54%) on September 30, 2024.
- Over the past year, BIIB quarterly current liabilities has increased by +$2.32 billion (+74.54%).
- BIIB quarterly current liabilities is now at all-time high.
Performance
BIIB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BIIB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.9% | +74.5% |
| 3 y3 years | -8.2% | +74.5% |
| 5 y5 years | +4.2% | +74.5% |
BIIB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +4.9% | at high | +79.9% |
| 5 y | 5-year | -29.4% | +4.9% | at high | +79.9% |
| alltime | all time | -29.4% | >+9999.0% | at high | >+9999.0% |
Biogen Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.42 B(+74.5%) |
| Jun 2024 | - | $3.11 B(-3.6%) |
| Mar 2024 | - | $3.22 B(-6.2%) |
| Dec 2023 | $3.43 B(+4.9%) | $3.43 B(-31.6%) |
| Sep 2023 | - | $5.02 B(+57.6%) |
| Jun 2023 | - | $3.19 B(+5.7%) |
| Mar 2023 | - | $3.01 B(-7.9%) |
| Dec 2022 | $3.27 B(-23.9%) | $3.27 B(-16.6%) |
| Sep 2022 | - | $3.93 B(-21.8%) |
| Jun 2022 | - | $5.02 B(+27.1%) |
| Mar 2022 | - | $3.95 B(-8.2%) |
| Dec 2021 | $4.30 B(+14.9%) | $4.30 B(+2.1%) |
| Sep 2021 | - | $4.21 B(+25.8%) |
| Jun 2021 | - | $3.35 B(+5.7%) |
| Mar 2021 | - | $3.17 B(-15.4%) |
| Dec 2020 | $3.74 B(-23.1%) | $3.74 B(-1.6%) |
| Sep 2020 | - | $3.80 B(+10.4%) |
| Jun 2020 | - | $3.45 B(-25.7%) |
| Mar 2020 | - | $4.64 B(-4.6%) |
| Dec 2019 | $4.86 B(+47.6%) | $4.86 B(+9.7%) |
| Sep 2019 | - | $4.43 B(+38.0%) |
| Jun 2019 | - | $3.21 B(+2.0%) |
| Mar 2019 | - | $3.15 B(-4.4%) |
| Dec 2018 | $3.30 B(-2.2%) | $3.30 B(+3.8%) |
| Sep 2018 | - | $3.17 B(+0.7%) |
| Jun 2018 | - | $3.15 B(+0.0%) |
| Mar 2018 | - | $3.15 B(-6.4%) |
| Dec 2017 | $3.37 B(-1.5%) | $3.37 B(-2.3%) |
| Sep 2017 | - | $3.45 B(+2.0%) |
| Jun 2017 | - | $3.38 B(+12.9%) |
| Mar 2017 | - | $2.99 B(-12.5%) |
| Dec 2016 | $3.42 B(+32.7%) | $3.42 B(+36.8%) |
| Sep 2016 | - | $2.50 B(-0.7%) |
| Jun 2016 | - | $2.52 B(-9.4%) |
| Mar 2016 | - | $2.78 B(+7.7%) |
| Dec 2015 | $2.58 B(+16.2%) | $2.58 B(-2.1%) |
| Sep 2015 | - | $2.63 B(+3.1%) |
| Jun 2015 | - | $2.56 B(+31.3%) |
| Mar 2015 | - | $1.95 B(-12.3%) |
| Dec 2014 | $2.22 B(+26.2%) | $2.22 B(+14.3%) |
| Sep 2014 | - | $1.94 B(+1.3%) |
| Jun 2014 | - | $1.92 B(+20.2%) |
| Mar 2014 | - | $1.59 B(-9.3%) |
| Dec 2013 | $1.76 B(+6.1%) | $1.76 B(+15.8%) |
| Sep 2013 | - | $1.52 B(+16.5%) |
| Jun 2013 | - | $1.30 B(+1.7%) |
| Mar 2013 | - | $1.28 B(-22.7%) |
| Dec 2012 | $1.66 B(+81.6%) | $1.66 B(+9.0%) |
| Sep 2012 | - | $1.52 B(+6.2%) |
| Jun 2012 | - | $1.43 B(+7.1%) |
| Mar 2012 | - | $1.34 B(+46.5%) |
| Dec 2011 | $912.89 M(-13.1%) | $912.89 M(+3.1%) |
| Sep 2011 | - | $885.35 M(-7.2%) |
| Jun 2011 | - | $954.33 M(-2.5%) |
| Mar 2011 | - | $978.85 M(-6.8%) |
| Dec 2010 | $1.05 B(+46.9%) | $1.05 B(+27.4%) |
| Sep 2010 | - | $824.48 M(+9.1%) |
| Jun 2010 | - | $755.66 M(+10.7%) |
| Mar 2010 | - | $682.33 M(-4.6%) |
| Dec 2009 | $714.94 M(-22.6%) | $714.94 M(-0.9%) |
| Sep 2009 | - | $721.37 M(-10.3%) |
| Jun 2009 | - | $803.93 M(-0.5%) |
| Mar 2009 | - | $807.77 M(-12.5%) |
| Dec 2008 | $923.22 M(-57.8%) | $923.22 M(-6.4%) |
| Sep 2008 | - | $985.87 M(+11.3%) |
| Jun 2008 | - | $885.44 M(+25.2%) |
| Mar 2008 | - | $707.17 M(-67.7%) |
| Dec 2007 | $2.19 B(+275.6%) | $2.19 B(+10.1%) |
| Sep 2007 | - | $1.99 B(-42.6%) |
| Jun 2007 | - | $3.46 B(+592.4%) |
| Mar 2007 | - | $500.45 M(-14.1%) |
| Dec 2006 | $582.86 M | $582.86 M(+17.7%) |
| Sep 2006 | - | $495.01 M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $499.98 M(-4.0%) |
| Mar 2006 | - | $520.80 M(-12.9%) |
| Dec 2005 | $597.81 M(-52.6%) | $597.81 M(+7.0%) |
| Sep 2005 | - | $558.95 M(+3.4%) |
| Jun 2005 | - | $540.65 M(-56.0%) |
| Mar 2005 | - | $1.23 B(-2.6%) |
| Dec 2004 | $1.26 B(+211.4%) | $1.26 B(+194.2%) |
| Sep 2004 | - | $428.60 M(+8.1%) |
| Jun 2004 | - | $396.64 M(+9.3%) |
| Mar 2004 | - | $362.83 M(-10.4%) |
| Dec 2003 | $404.82 M(+620.0%) | $404.82 M(+42.7%) |
| Sep 2003 | - | $283.63 M(+17.9%) |
| Jun 2003 | - | $240.49 M(-11.3%) |
| Mar 2003 | - | $271.01 M(+382.0%) |
| Dec 2002 | $56.23 M(-80.9%) | $56.23 M(-79.5%) |
| Sep 2002 | - | $274.00 M(-5.9%) |
| Jun 2002 | - | $291.21 M(+5.1%) |
| Mar 2002 | - | $277.01 M(-6.1%) |
| Dec 2001 | $294.94 M(+33.4%) | $294.94 M(+15.7%) |
| Sep 2001 | - | $254.95 M(+8.5%) |
| Jun 2001 | - | $234.98 M(+3.9%) |
| Mar 2001 | - | $226.19 M(+2.3%) |
| Dec 2000 | $221.02 M(+16.2%) | $221.02 M(-6.3%) |
| Sep 2000 | - | $235.81 M(+11.1%) |
| Jun 2000 | - | $212.16 M(+30.4%) |
| Mar 2000 | - | $162.68 M(-14.5%) |
| Dec 1999 | $190.27 M(+45.6%) | $190.27 M(+48.3%) |
| Sep 1999 | - | $128.30 M(+7.8%) |
| Jun 1999 | - | $119.00 M(+7.7%) |
| Mar 1999 | - | $110.50 M(-15.4%) |
| Dec 1998 | $130.66 M(+5.5%) | $130.66 M(-0.7%) |
| Sep 1998 | - | $131.60 M(+24.6%) |
| Jun 1998 | - | $105.60 M(-8.5%) |
| Mar 1998 | - | $115.40 M(-6.8%) |
| Dec 1997 | $123.88 M(+40.9%) | $123.88 M(+29.2%) |
| Sep 1997 | - | $95.90 M(+17.4%) |
| Jun 1997 | - | $81.70 M(-0.8%) |
| Mar 1997 | - | $82.40 M(-6.3%) |
| Dec 1996 | $87.95 M(+64.7%) | $87.95 M(+32.7%) |
| Sep 1996 | - | $66.30 M(+3.0%) |
| Jun 1996 | - | $64.40 M(+27.0%) |
| Mar 1996 | - | $50.70 M(-5.0%) |
| Dec 1995 | $53.40 M(+11.4%) | $53.40 M(+24.5%) |
| Sep 1995 | - | $42.90 M(+10.9%) |
| Jun 1995 | - | $38.70 M(-2.0%) |
| Mar 1995 | - | $39.50 M(-17.6%) |
| Dec 1994 | $47.93 M(+50.7%) | $47.93 M(-18.1%) |
| Sep 1994 | - | $58.50 M(+78.4%) |
| Jun 1994 | - | $32.80 M(+11.2%) |
| Mar 1994 | - | $29.50 M(-7.2%) |
| Dec 1993 | $31.80 M(+21.4%) | $31.80 M(+4.6%) |
| Sep 1993 | - | $30.40 M(-15.6%) |
| Jun 1993 | - | $36.00 M(+60.0%) |
| Mar 1993 | - | $22.50 M(-14.1%) |
| Dec 1992 | $26.20 M(+85.8%) | $26.20 M(+25.4%) |
| Sep 1992 | - | $20.90 M(+51.4%) |
| Jun 1992 | - | $13.80 M(+20.0%) |
| Mar 1992 | - | $11.50 M(-18.4%) |
| Dec 1991 | $14.10 M(+11.0%) | $14.10 M(+8.5%) |
| Sep 1991 | - | $13.00 M(+9.2%) |
| Jun 1991 | - | $11.90 M(+16.7%) |
| Mar 1991 | - | $10.20 M(-19.7%) |
| Dec 1990 | $12.70 M(+111.7%) | $12.70 M(+44.3%) |
| Sep 1990 | - | $8.80 M(+25.7%) |
| Jun 1990 | - | $7.00 M(+20.7%) |
| Mar 1990 | - | $5.80 M(-3.3%) |
| Dec 1989 | $6.00 M(-25.0%) | $6.00 M(-7.7%) |
| Sep 1989 | - | $6.50 M(-18.8%) |
| Dec 1988 | $8.00 M(+5.3%) | $8.00 M(+5.3%) |
| Dec 1987 | $7.60 M(+5.6%) | $7.60 M(+5.6%) |
| Dec 1986 | $7.20 M(-2.7%) | $7.20 M(-2.7%) |
| Dec 1985 | $7.40 M(-50.3%) | $7.40 M(-50.3%) |
| Dec 1984 | $14.90 M | $14.90 M |
FAQ
- What is Biogen annual total current liabilities?
- What is the all time high annual current liabilities for Biogen?
- What is Biogen annual current liabilities year-on-year change?
- What is Biogen quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Biogen?
- What is Biogen quarterly current liabilities year-on-year change?
What is Biogen annual total current liabilities?
The current annual current liabilities of BIIB is $3.43 B
What is the all time high annual current liabilities for Biogen?
Biogen all-time high annual total current liabilities is $4.86 B
What is Biogen annual current liabilities year-on-year change?
Over the past year, BIIB annual total current liabilities has changed by +$161.50 M (+4.93%)
What is Biogen quarterly total current liabilities?
The current quarterly current liabilities of BIIB is $5.42 B
What is the all time high quarterly current liabilities for Biogen?
Biogen all-time high quarterly total current liabilities is $5.42 B
What is Biogen quarterly current liabilities year-on-year change?
Over the past year, BIIB quarterly total current liabilities has changed by +$2.32 B (+74.54%)